Skip to content

Clinical trials

Observational Cardiomyopathy, Dilated trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Phase: Observational Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20072
20091
20121
20133
20141
20182
20212
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Active, not recruiting3
Unknown status2
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University2
Wayne State University2
Alexion Pharmaceuticals, Inc.1
Baylor College of Medicine1
Carelon Research1
Catholic University of the Sacred Heart1
Emory University1
Indiana University1
National Heart, Lung, and Blood Institute (NHLBI)1
Ohio State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated20
Cardiomyopathy, Hypertrophic9
Heart Failure9
Cardiomyopathies4
Cardiomyopathy, Restrictive4
Heart Diseases3
Arrhythmogenic Right Ventricular Dysplasia2
Cardiovascular Diseases2
Death, Sudden, Cardiac2
Muscular Dystrophies2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.